Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)
CNY 21.47
(6.93%)
CNY 21.47
(6.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 299.01 Million | 261.89 Million | 320.95 Million | 244.35 Million | 241.49 Million | 130.08 Million |
| Net Income | 98.55 Million | 106.68 Million | 151.2 Million | -126.92 Million | 53.95 Million | 65.85 Million |
| Depreciation & Amortization | 143.6 Million | 138.2 Million | 124.62 Million | 103.31 Million | 96.25 Million | 102.04 Million |
| Deferred income taxes | -37.28 Million | -7.29 Million | 18.49 Million | -6.42 Million | 17.3 Million | -3.45 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -59.83 Million | -31.8 Million | 64.08 Million | 25.63 Million | -31.43 Million | -58.98 Million |
| Other non-cash items | 28.32 Million | 48.8 Million | -18.96 Million | 242.32 Million | 122.72 Million | 21.17 Million |
| Investing Cash Flow | -90.49 Million | -98.34 Million | -134.05 Million | 308.09 Million | -555.14 Million | -4.24 Million |
| Investments in PPE | -88.61 Million | -99.19 Million | -127.73 Million | -91.71 Million | -122.95 Million | -128.13 Million |
| Acquisitions | 18.73 Million | 37.47 Million | 12.28 Million | 11.57 Million | 132.21 Million | 163.08 Million |
| Investment purchases | -17.66 Million | -8.53 Million | -83.92 Million | -620.69 Million | -675.72 Million | -327 Million |
| Sales/Maturities of investments | 15.6 Million | 7.96 Million | 64.98 Million | 1 Billion | 234.27 Million | 287.85 Million |
| Other Investing Activities | -1.87 Million | -36.04 Million | 348.61 Thousand | -525.47 Thousand | -122.95 Million | -53.11 Thousand |
| Financing Cash Flow | -18.72 Million | -7.74 Million | -49.7 Million | -104.96 Million | 356.79 Million | -25.42 Million |
| Debt repayment | -6.3 Million | -6.3 Million | -6.3 Million | -105.03 Million | -87.07 Million | -41.47 Million |
| Dividends payments | -917.34 Thousand | -1.26 Million | -1.6 Million | -4.02 Million | -11.34 Million | -11.66 Million |
| Common Stock Repurchased | - | - | - | -315.12 Thousand | -95.2 Thousand | -17.24 Million |
| Common Stock Issuance | - | - | - | 315.12 Thousand | 95.2 Thousand | - |
| Other Financing Activities | -10.89 Million | -170.39 Thousand | -41.79 Million | 12.88 Million | 455.2 Million | 27.71 Million |
| Accounts receivables | -12.22 Million | -31.92 Million | 30.72 Million | 67.7 Million | -43.6 Million | -79.9 Million |
| Accounts payables | -1.07 Million | 35.05 Million | 19.41 Million | -29.75 Million | 27.92 Million | 37.78 Million |
| Inventory | -9.24 Million | -27.64 Million | -4.55 Million | -5.88 Million | -33.06 Million | -13.4 Million |
| Other working capital | 12.2 Million | -7.29 Million | 18.49 Million | -6.42 Million | 17.3 Million | -45.58 Million |
| Cash at beginning of period | 1.38 Billion | 1.19 Billion | 1.06 Billion | 631.69 Million | 585.24 Million | 475.92 Million |
| Cash at end of period | 1.58 Billion | 1.38 Billion | 1.19 Billion | 1.06 Billion | 631.69 Million | 585.24 Million |
| Capital Expenditure | -88.61 Million | -99.19 Million | -127.73 Million | -91.71 Million | -122.95 Million | -128.13 Million |
| Effect of forex changes on cash | 10.22 Million | 35.29 Million | -7.44 Million | -18.85 Million | 3.3 Million | 8.9 Million |
| Net cash flow / Change in cash | 200.01 Million | 191.09 Million | 129.75 Million | 428.62 Million | 46.44 Million | 109.31 Million |
| Free Cash Flow | 210.4 Million | 162.69 Million | 193.21 Million | 152.63 Million | 118.53 Million | 1.94 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 48.32 Million | 45.03 Million | 40.14 Million | -26.05 Million | 98.55 Million | 49.83 Million |
| Depreciation & Amortization | - | 38.26 Million | 38.26 Million | 39.93 Million | 143.6 Million | -68.69 Million |
| Deferred income taxes | - | - | - | - | -37.28 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -65.11 Million | - | -9.27 Million | -59.83 Million | 55.93 Million |
| Other non-cash items | 30.38 Million | 70.61 Million | -18.9 Million | 179.39 Million | 28.32 Million | 35.59 Million |
| Investing Cash Flow | -11.64 Million | -21.05 Million | -20.37 Million | -28.53 Million | -90.49 Million | -16.71 Million |
| Investments in PPE | -11.91 Million | -20.79 Million | -20.5 Million | -28.54 Million | -88.61 Million | -17.32 Million |
| Acquisitions | 269.24 Thousand | 310.07 Thousand | 126.78 Thousand | 11.54 Thousand | 18.73 Million | 616.91 Thousand |
| Investment purchases | -256.00 | -568.42 Thousand | - | -3112.00 | -17.66 Million | -5.1 Million |
| Sales/Maturities of investments | - | - | - | - | 15.6 Million | 5.6 Million |
| Other Investing Activities | 269.24 Thousand | -258.35 Thousand | 126.78 Thousand | 8431.00 | -1.87 Million | -499.99 Thousand |
| Financing Cash Flow | -76 Million | -124.76 Million | -63.81 Million | -8.86 Million | -18.72 Million | -6 Million |
| Debt repayment | -1.57 Million | -1.57 Million | -1.57 Million | -1.57 Million | -6.3 Million | -1.57 Million |
| Dividends payments | -135.89 Thousand | -161.62 Thousand | -177.61 Thousand | -195.35 Thousand | -917.34 Thousand | -215.84 Thousand |
| Common Stock Repurchased | 167.69 Million | -167.69 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -74.29 Million | -116.97 Million | -62.23 Million | -7.09 Million | -10.89 Million | -4.21 Million |
| Accounts receivables | - | -50.8 Million | - | -12.22 Million | -12.22 Million | 34.06 Million |
| Accounts payables | - | - | - | - | -1.07 Million | - |
| Inventory | - | -14.3 Million | - | -9.24 Million | -9.24 Million | 21.86 Million |
| Other working capital | - | - | - | 12.2 Million | 12.2 Million | - |
| Cash at beginning of period | 1.45 Billion | 1.52 Billion | 1.52 Billion | 1.5 Billion | 1.38 Billion | 1.46 Billion |
| Cash at end of period | 1.43 Billion | 1.45 Billion | 1.52 Billion | 1.58 Billion | 1.58 Billion | 1.5 Billion |
| Capital Expenditure | -11.91 Million | -20.79 Million | -20.5 Million | -28.54 Million | -88.61 Million | -17.32 Million |
| Effect of forex changes on cash | -6.04 Million | 1.91 Million | 1.79 Million | -4.73 Million | 10.22 Million | -3.3 Million |
| Net cash flow / Change in cash | -14.98 Million | -66.68 Million | -2.11 Million | 71.26 Million | 200.01 Million | 46.64 Million |
| Free Cash Flow | 66.8 Million | 56.58 Million | 743.25 Thousand | 84.86 Million | 210.4 Million | 55.34 Million |
TRKNY
4772
7875
PBATF
6993
LEN